Headlines
Below is a list of clinical trials ongoing within the INNODIA Network that are currently recruiting or will be recruiting in the near future, and for which you can submit a request using the contact email address displayed for each study. Patients are encouraged to discuss their participation in a clinical trial with their physician and the investigators at the clinical trial site.
The below list is not exhaustive of all T1D studies available in the world. To search for additional options, please visit CTIS or clinicaltrials.gov
Clinical Trials open to enrolment
βeta PRESERVE
The goal of this study is to evaluate whether teplizumab provides superior glycemic control or reduces the need for prandial insulin, compared to placebo, in participants 1 to 25 years of age recently diagnosed with Type 1 Diabetes.
Find out more about this clinical trial
IMC-S118AI-1007
The goal of this study is to evaluate the safety and tolerability of IMC-S118AI when administered as a single and multiple doses in participants with Type 1 Diabetes (T1D).
Find out more about this clinical trial.
Are you a person living with T1D (from stage 1 to stage 4) and would like to discover which clinical trials, surveys, or panels may match your profile?
Running Clinical trials closed to enrolment
Below is a list of previously launched clinical trials for which patient recruitment has now been completed.
They are still in follow-up.
Safeguard
The goal of this study is to evaluate if a new medicine, SAB-142, can help slow the decline of insulin-producing cells in the pancreas over the course of the study.
Find out more about this clinical trial
FrexalimAB in Preservation of Endogenous insULIN Secretion (FABULINUS)
The goal of this study is to determine if treatment with Frexalimab preserves endogenous insulin secretion compared to placebo in adults and adolescents on top of insulin therapy.
THIS CLINICAL TRIAL IS RECRUITING FOR PART B ONLY
Innodia can help you set up your clinical trial
Are you wanting to design, execute and run a clinical study in type 1 diabetes in a given time?
By mobilising its Network of accredited sites and providing ongoing, high-performance support throughout each clinical trial, INNODIA is your preferred partner for testing your disease-modifying therapy.